Yibin Zeng

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study

Pirow Bekker, Daniel J. Dairaghi, Lisa Seitz et al. · PLoS ONE · 2016 · 150 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Syntheses of the <i>Stemona</i> Alkaloids (±)-Stenine, (±)-Neostenine, and (±)-13-Epineostenine Using a Stereodivergent Diels–Alder/Azido-Schmidt Reaction

Kevin J. Frankowski, Jennifer E. Golden, Yibin Zeng et al. · Journal of the American Chemical Society · 2008 · 117 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +11

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Daniel J. Dairaghi, Babatunde O. Oyajobi, Anjana Gupta et al. · Blood · 2012 · 86 citations · Full text

Medicine, Cancer Biology, Oncology +16

An Expeditious Total Synthesis of (±)-Stenine

Yibin Zeng, Jeffrey Aubé · Journal of the American Chemical Society · 2005 · 78 citations

Natural Sciences, Chemistry, Organic Chemistry +8

Sequential Pd(II)−Pd(0) Catalysis for the Rapid Synthesis of Coumarins

Kelin Li, Yibin Zeng, Ben Neuenswander et al. · The Journal of Organic Chemistry · 2005 · 61 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13